Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Casper Reijnen

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 17, 2022
Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancerMajke H D van Bommel, Johanna M A Pijnenborg, Louis J M van der Putten, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|January 8, 2024
Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?Stephanie W Vrede, Hannah Donkers, Casper Reijnen, et al.
International Journal of Cancer|February 6, 2020
Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcomeCasper Reijnen, Heidi V N Küsters-Vandevelde, Marjolijn J L Ligtenberg, et al.
International Journal of Cancer|September 17, 2019
Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort studyCasper Reijnen, Louis J M van der Putten, Johan Bulten, et al.
Human Pathology|December 18, 2020
The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration studyWillem Jan van Weelden, Casper Reijnen, Heidi V N Küsters-Vandevelde, et al.
Gynecologic Oncology|November 8, 2024
Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancerStephanie W Vrede, Willem Jan Van Weelden, Johan Bulten, et al.
JAMA Network Open|December 16, 2022
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial CancerStephanie W Vrede, Jenneke Kasius, Johan Bulten, et al.
Human Pathology|August 21, 2021
Improving preoperative diagnosis in endometrial cancer using systematic morphological assessment and a small immunohistochemical panelNicole C M Visser, Anneke A M van der Wurff, Joanna IntHout, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2025
ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessmentMarike S Lombaers, Casper Reijnen, Ally Sprik, et al.
Cancers|May 13, 2023
Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial CancerMarike S Lombaers, Karlijn M C Cornel, Nicole C M Visser, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 17, 2022
Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancerMajke H D van Bommel, Johanna M A Pijnenborg, Louis J M van der Putten, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|January 8, 2024
Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?Stephanie W Vrede, Hannah Donkers, Casper Reijnen, et al.
International Journal of Cancer|February 6, 2020
Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcomeCasper Reijnen, Heidi V N Küsters-Vandevelde, Marjolijn J L Ligtenberg, et al.
International Journal of Cancer|September 17, 2019
Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort studyCasper Reijnen, Louis J M van der Putten, Johan Bulten, et al.
Human Pathology|December 18, 2020
The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration studyWillem Jan van Weelden, Casper Reijnen, Heidi V N Küsters-Vandevelde, et al.
Gynecologic Oncology|November 8, 2024
Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancerStephanie W Vrede, Willem Jan Van Weelden, Johan Bulten, et al.
JAMA Network Open|December 16, 2022
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial CancerStephanie W Vrede, Jenneke Kasius, Johan Bulten, et al.
Human Pathology|August 21, 2021
Improving preoperative diagnosis in endometrial cancer using systematic morphological assessment and a small immunohistochemical panelNicole C M Visser, Anneke A M van der Wurff, Joanna IntHout, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2025
ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessmentMarike S Lombaers, Casper Reijnen, Ally Sprik, et al.
Cancers|May 13, 2023
Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial CancerMarike S Lombaers, Karlijn M C Cornel, Nicole C M Visser, et al.
Pageof 4